Ubs Group Ag Elanco Animal Health Inc Call Options Transaction History

Ubs Group Ag

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$11.85 - $15.47 $3.98 Million - $5.19 Million	-335,800 Reduced 87.04%	50,000 $734,000
Q2 2024 Aug 13, 2024	BUY	$12.93 - $18.45 $4.99 Million - $7.12 Million	385,800 New	385,800 $5.57 Million
Q1 2023 May 12, 2023	BUY	$8.79 - $14.58 $659,249 - $1.09 Million	75,000 New	75,000 $705,000
Q3 2022 Nov 10, 2022	BUY	$12.41 - $32.42 $3.56 Million - $9.31 Million	287,100 New	287,100 $3.56 Million
Q3 2021 Nov 15, 2021	SELL	$29.2 - $36.72 $1.26 Million - $1.58 Million	-43,010 Reduced 33.86%	83,996 $2.68 Million
Q1 2021 May 12, 2021	SELL	$27.85 - $34.49 $640,382 - $793,063	-22,994 Reduced 15.33%	127,006 $3.74 Million
Q1 2020 May 01, 2020	BUY	$16.68 - $32.25 $2.5 Million - $4.84 Million	150,000 New	150,000 $3.36 Million

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.